Skip to main content
Erschienen in: Current Diabetes Reports 10/2017

01.10.2017 | Therapies and New Technologies in the Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor)

Management of Type 1 Diabetes in the Hospital Setting

verfasst von: Carlos E. Mendez, Guillermo E. Umpierrez

Erschienen in: Current Diabetes Reports | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of this article was to review recent guideline recommendations on glycemic target, glucose monitoring, and therapeutic strategies, while providing practical recommendations for the management of medical and surgical patients with type 1 diabetes (T1D) admitted to critical and non-critical care settings.

Recent Findings

Studies evaluating safety and efficacy of insulin pump therapy, continuous glucose monitoring, electronic glucose management systems, and closed loop systems for the inpatient management of hyperglycemia are described.

Summary

Due to the increased prevalence and life expectancy of patients with type 1 diabetes, a growing number of these patients require hospitalization every year. Inpatient diabetes management is complex and is best provided by a multidisciplinary diabetes team. In the absence of such resource, providers and health care staff must become familiar with the features of this condition to avoid complications such as severe hyperglycemia, ketoacidosis, hypoglycemia, or glycemic variability. We reviewed most recent guidelines and relevant literature in the topic to provide practical recommendations for the inpatient management of patients with T1D.
Literatur
1.
Zurück zum Zitat Chiang JL, Kirkman MS, Laffel LM, Peters AL. Type 1 diabetes sourcebook authors. Type 1 diabetes through the life span: A position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034–54.CrossRefPubMed Chiang JL, Kirkman MS, Laffel LM, Peters AL. Type 1 diabetes sourcebook authors. Type 1 diabetes through the life span: A position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034–54.CrossRefPubMed
3.
Zurück zum Zitat Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin N Am. 2010;39(3):481–97.CrossRef Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin N Am. 2010;39(3):481–97.CrossRef
4.
Zurück zum Zitat • Sayers A, Thayer D, Harvey JN, Luzio S, Atkinson MD, French R, et al. Evidence for a persistent, major excess in all cause admissions to hospital in children with type-1 diabetes: Results from a large welsh national matched community cohort study. BMJ Open. 2015;(4):5, e005644. This study shows the increased rates of hospitalizations in patients with T1D compared to general population • Sayers A, Thayer D, Harvey JN, Luzio S, Atkinson MD, French R, et al. Evidence for a persistent, major excess in all cause admissions to hospital in children with type-1 diabetes: Results from a large welsh national matched community cohort study. BMJ Open. 2015;(4):5, e005644. This study shows the increased rates of hospitalizations in patients with T1D compared to general population
5.
Zurück zum Zitat Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet. 2009;373(9680):2027–33.CrossRefPubMed Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet. 2009;373(9680):2027–33.CrossRefPubMed
6.
7.
Zurück zum Zitat Icks A, Rosenbauer J, Holl RW, Grabert M, Rathmann W, Giani G, et al. Hospitalization among diabetic children and adolescents and the general population in Germany. German working Group for Pediatric Diabetology. Diabetes Care. 2001;24(3):435–40.CrossRefPubMed Icks A, Rosenbauer J, Holl RW, Grabert M, Rathmann W, Giani G, et al. Hospitalization among diabetic children and adolescents and the general population in Germany. German working Group for Pediatric Diabetology. Diabetes Care. 2001;24(3):435–40.CrossRefPubMed
8.
Zurück zum Zitat Tomlin AM, Tilyard MW, Dovey SM, Dawson AG. Hospital admissions in diabetic and non-diabetic patients: A case-control study. Diabetes Res Clin Pract. 2006;73(3):260–7.CrossRefPubMed Tomlin AM, Tilyard MW, Dovey SM, Dawson AG. Hospital admissions in diabetic and non-diabetic patients: A case-control study. Diabetes Res Clin Pract. 2006;73(3):260–7.CrossRefPubMed
9.
Zurück zum Zitat Donnan PT, Leese GP, Morris AD. Diabetes audit and research in Tayside, Scotland/medicine monitoring unit collaboration. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: A retrospective cohort study of resource use. Diabetes Care. 2000;23(12):1774–9.CrossRefPubMed Donnan PT, Leese GP, Morris AD. Diabetes audit and research in Tayside, Scotland/medicine monitoring unit collaboration. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: A retrospective cohort study of resource use. Diabetes Care. 2000;23(12):1774–9.CrossRefPubMed
10.
Zurück zum Zitat Angus VC, Waugh N. Hospital admission patterns subsequent to diagnosis of type 1 diabetes in children : A systematic review. BMC Health Serv Res. 2007;7:199.CrossRefPubMedPubMedCentral Angus VC, Waugh N. Hospital admission patterns subsequent to diagnosis of type 1 diabetes in children : A systematic review. BMC Health Serv Res. 2007;7:199.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Robertshaw HJ, Hall GM. Diabetes mellitus: Anaesthetic management. Anaesthesia. 2006;61(12):1187–90.CrossRefPubMed Robertshaw HJ, Hall GM. Diabetes mellitus: Anaesthetic management. Anaesthesia. 2006;61(12):1187–90.CrossRefPubMed
12.
Zurück zum Zitat Umpierrez GE, Kitabchi AE. Diabetic ketoacidosis: Risk factors and management strategies. Treat Endocrinol. 2003;2(2):95–108.CrossRefPubMed Umpierrez GE, Kitabchi AE. Diabetic ketoacidosis: Risk factors and management strategies. Treat Endocrinol. 2003;2(2):95–108.CrossRefPubMed
13.
Zurück zum Zitat Cryer PE. Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin N Am. 2010;39(3):641–54.CrossRef Cryer PE. Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin N Am. 2010;39(3):641–54.CrossRef
14.
Zurück zum Zitat Mendez CE, Umpierrez G. Management of the hospitalized patient with type 1 diabetes mellitus. Hosp Pract (1995). 2013;41(3):89–100.CrossRef Mendez CE, Umpierrez G. Management of the hospitalized patient with type 1 diabetes mellitus. Hosp Pract (1995). 2013;41(3):89–100.CrossRef
15.
Zurück zum Zitat Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.CrossRefPubMed Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.CrossRefPubMed
16.
Zurück zum Zitat Krinsley JS, Egi M, Kiss A, Devendra AN, Schuetz P, Maurer PM, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: An international multicenter cohort study. Crit Care. 2013;17(2):R37.CrossRefPubMedPubMedCentral Krinsley JS, Egi M, Kiss A, Devendra AN, Schuetz P, Maurer PM, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: An international multicenter cohort study. Crit Care. 2013;17(2):R37.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Viens NA, Hug KT, Marchant MH, Cook C, Vail TP, Bolognesi MP. Role of diabetes type in perioperative outcomes after hip and knee arthroplasty in the United States. J Surg Orthop Adv. 2012;21(4):253–60.CrossRefPubMed Viens NA, Hug KT, Marchant MH, Cook C, Vail TP, Bolognesi MP. Role of diabetes type in perioperative outcomes after hip and knee arthroplasty in the United States. J Surg Orthop Adv. 2012;21(4):253–60.CrossRefPubMed
18.
Zurück zum Zitat Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–91.CrossRefPubMed Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–91.CrossRefPubMed
19.
Zurück zum Zitat American Diabetes Association. Standards of medical Care in Diabetes-2017 abridged for primary care providers. Clin Diabetes. 2017;35(1):5–26.CrossRef American Diabetes Association. Standards of medical Care in Diabetes-2017 abridged for primary care providers. Clin Diabetes. 2017;35(1):5–26.CrossRef
20.
Zurück zum Zitat Simmons D, Hartnell S, Watts J, Ward C, Davenport K, Gunn E, et al. Effectiveness of a multidisciplinary team approach to the prevention of readmission for acute glycaemic events. Diabet Med. 2015;32(10):1361–7.CrossRefPubMed Simmons D, Hartnell S, Watts J, Ward C, Davenport K, Gunn E, et al. Effectiveness of a multidisciplinary team approach to the prevention of readmission for acute glycaemic events. Diabet Med. 2015;32(10):1361–7.CrossRefPubMed
21.
Zurück zum Zitat Cook CB, Castro JC, Schmidt RE, Gauthier SM, Whitaker MD, Roust LR, et al. Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007;2(4):203–11.CrossRefPubMed Cook CB, Castro JC, Schmidt RE, Gauthier SM, Whitaker MD, Roust LR, et al. Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007;2(4):203–11.CrossRefPubMed
22.
Zurück zum Zitat Cook CB, Kongable GL, Potter DJ, Abad VJ, Leija DE, Anderson M. Inpatient glucose control: A glycemic survey of 126 U.S. hospitals. J Hosp Med. 2009;4(9):E7–E14.CrossRefPubMed Cook CB, Kongable GL, Potter DJ, Abad VJ, Leija DE, Anderson M. Inpatient glucose control: A glycemic survey of 126 U.S. hospitals. J Hosp Med. 2009;4(9):E7–E14.CrossRefPubMed
23.
Zurück zum Zitat Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: A clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of diabetes and the American Diabetes Association diabetes technology working group. Diabetologia. 2015;58(5):862–70.CrossRefPubMed Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: A clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of diabetes and the American Diabetes Association diabetes technology working group. Diabetologia. 2015;58(5):862–70.CrossRefPubMed
24.
Zurück zum Zitat Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: An update. Anesthesiology. 2017;126(3):547–60.CrossRefPubMed Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: An update. Anesthesiology. 2017;126(3):547–60.CrossRefPubMed
25.
Zurück zum Zitat Bailon RM, Partlow BJ, Miller-Cage V, Boyle ME, Castro JC, Bourgeois PB, et al. Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. Endocr Pract. 2009;15(1):24–9.CrossRefPubMed Bailon RM, Partlow BJ, Miller-Cage V, Boyle ME, Castro JC, Bourgeois PB, et al. Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. Endocr Pract. 2009;15(1):24–9.CrossRefPubMed
26.
Zurück zum Zitat Cook CB, Boyle ME, Cisar NS, Miller-Cage V, Bourgeois P, Roust LR, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: Proposed guidelines and outcome measures. Diabetes Educ. 2005;31(6):849–57.CrossRefPubMed Cook CB, Boyle ME, Cisar NS, Miller-Cage V, Bourgeois P, Roust LR, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: Proposed guidelines and outcome measures. Diabetes Educ. 2005;31(6):849–57.CrossRefPubMed
27.
Zurück zum Zitat Yogi-Morren D, Lansang MC. Management of patients with type 1 diabetes in the hospital. Curr Diab Rep. 2014;14(2):458.CrossRefPubMed Yogi-Morren D, Lansang MC. Management of patients with type 1 diabetes in the hospital. Curr Diab Rep. 2014;14(2):458.CrossRefPubMed
28.
Zurück zum Zitat Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am. 2017;101(3):587–606.CrossRefPubMed Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am. 2017;101(3):587–606.CrossRefPubMed
29.
Zurück zum Zitat Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–32.CrossRefPubMed Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–32.CrossRefPubMed
30.
Zurück zum Zitat Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.CrossRefPubMedPubMedCentral Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Smiley D, Rhee M, Peng L, Roediger L, Mulligan P, Satterwhite L, et al. Safety and efficacy of continuous insulin infusion in noncritical care settings. J Hosp Med. 2010;5(4):212–7.CrossRefPubMedPubMedCentral Smiley D, Rhee M, Peng L, Roediger L, Mulligan P, Satterwhite L, et al. Safety and efficacy of continuous insulin infusion in noncritical care settings. J Hosp Med. 2010;5(4):212–7.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Juneja R, Foster SA, Whiteman D, Fahrbach JL. The nuts and bolts of subcutaneous insulin therapy in non-critical care hospital settings. Postgrad Med. 2010;122(1):153–62.CrossRefPubMed Juneja R, Foster SA, Whiteman D, Fahrbach JL. The nuts and bolts of subcutaneous insulin therapy in non-critical care hospital settings. Postgrad Med. 2010;122(1):153–62.CrossRefPubMed
33.
Zurück zum Zitat Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709–28.CrossRefPubMed Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709–28.CrossRefPubMed
34.
Zurück zum Zitat Cobaugh DJ, Maynard G, Cooper L, Kienle PC, Vigersky R, Childers D, et al. Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70(16):1404–13.CrossRefPubMed Cobaugh DJ, Maynard G, Cooper L, Kienle PC, Vigersky R, Childers D, et al. Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70(16):1404–13.CrossRefPubMed
35.
Zurück zum Zitat American Diabetes Association. 14. Diabetes Care in the Hospital. Diabetes Care. 2017;40(Suppl 1):S120–7.CrossRef American Diabetes Association. 14. Diabetes Care in the Hospital. Diabetes Care. 2017;40(Suppl 1):S120–7.CrossRef
36.
Zurück zum Zitat Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778–85.CrossRefPubMed Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778–85.CrossRefPubMed
37.
Zurück zum Zitat Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: Confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403–9.CrossRefPubMed Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: Confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403–9.CrossRefPubMed
38.
Zurück zum Zitat Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, et al. Continuous glucose monitoring: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(10):2968–79.CrossRefPubMed Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, et al. Continuous glucose monitoring: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(10):2968–79.CrossRefPubMed
39.
Zurück zum Zitat •• Wallia A, Umpierrez GE, Nasraway SA, Klonoff DC. PRIDE investigators. Round table discussion on inpatient use of continuous glucose monitoring at the international hospital diabetes meeting. J Diabetes Sci Technol. 2016;10(5):1174–81. This article summarizes the potential advantages and disadvantages of using CGM in the hospital setting CrossRefPubMedPubMedCentral •• Wallia A, Umpierrez GE, Nasraway SA, Klonoff DC. PRIDE investigators. Round table discussion on inpatient use of continuous glucose monitoring at the international hospital diabetes meeting. J Diabetes Sci Technol. 2016;10(5):1174–81. This article summarizes the potential advantages and disadvantages of using CGM in the hospital setting CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Gottschalk A, Welp HA, Leser L, Lanckohr C, Wempe C, Ellger B. Continuous glucose monitoring in patients undergoing extracorporeal ventricular assist therapy. PLoS One. 2016;11(3):e0148778.CrossRefPubMedPubMedCentral Gottschalk A, Welp HA, Leser L, Lanckohr C, Wempe C, Ellger B. Continuous glucose monitoring in patients undergoing extracorporeal ventricular assist therapy. PLoS One. 2016;11(3):e0148778.CrossRefPubMedPubMedCentral
41.
42.
Zurück zum Zitat Kosiborod M, Gottlieb RK, Sekella JA, Peterman D, Grodzinsky A, Kennedy P, et al. Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. BMJ Open Diabetes Res Care. 2014;2(1):e000037.CrossRefPubMedPubMedCentral Kosiborod M, Gottlieb RK, Sekella JA, Peterman D, Grodzinsky A, Kennedy P, et al. Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. BMJ Open Diabetes Res Care. 2014;2(1):e000037.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Leelarathna L, English SW, Thabit H, Caldwell K, Allen JM, Kumareswaran K, et al. Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: Improved sensor performance with enhanced calibrations. Diabetes Technol Ther. 2014;16(2):97–101.CrossRefPubMedPubMedCentral Leelarathna L, English SW, Thabit H, Caldwell K, Allen JM, Kumareswaran K, et al. Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: Improved sensor performance with enhanced calibrations. Diabetes Technol Ther. 2014;16(2):97–101.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Boom DT, Sechterberger MK, Rijkenberg S, Kreder S, Bosman RJ, Wester JP, et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: A randomized controlled trial. Crit Care. 2014;18(4):453.CrossRefPubMedPubMedCentral Boom DT, Sechterberger MK, Rijkenberg S, Kreder S, Bosman RJ, Wester JP, et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: A randomized controlled trial. Crit Care. 2014;18(4):453.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Bridges BC, Preissig CM, Maher KO, Rigby MR. Continuous glucose monitors prove highly accurate in critically ill children. Crit Care. 2010;14(5):R176.CrossRefPubMedPubMedCentral Bridges BC, Preissig CM, Maher KO, Rigby MR. Continuous glucose monitors prove highly accurate in critically ill children. Crit Care. 2010;14(5):R176.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Thomas F, Signal M, Harris DL, Weston PJ, Harding JE, Shaw GM, et al. Continuous glucose monitoring in newborn infants: How do errors in calibration measurements affect detected hypoglycemia? J Diabetes Sci Technol. 2014;8(3):543–50.CrossRefPubMedPubMedCentral Thomas F, Signal M, Harris DL, Weston PJ, Harding JE, Shaw GM, et al. Continuous glucose monitoring in newborn infants: How do errors in calibration measurements affect detected hypoglycemia? J Diabetes Sci Technol. 2014;8(3):543–50.CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, et al. Current state of type 1 diabetes treatment in the U.S.: Updated data from the T1D exchange clinic registry. Diabetes Care. 2015;38(6):971–8.CrossRefPubMed Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, et al. Current state of type 1 diabetes treatment in the U.S.: Updated data from the T1D exchange clinic registry. Diabetes Care. 2015;38(6):971–8.CrossRefPubMed
48.
Zurück zum Zitat Murad MH, Coburn JA, Coto-Yglesias F, Dzyubak S, Hazem A, Lane MA, et al. Glycemic control in non-critically ill hospitalized patients: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(1):49–58.CrossRefPubMed Murad MH, Coburn JA, Coto-Yglesias F, Dzyubak S, Hazem A, Lane MA, et al. Glycemic control in non-critically ill hospitalized patients: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(1):49–58.CrossRefPubMed
49.
Zurück zum Zitat Whitham D. Nutrition management of diabetes in acute care. Can J Diabetes. 2014;38(2):90–3.CrossRefPubMed Whitham D. Nutrition management of diabetes in acute care. Can J Diabetes. 2014;38(2):90–3.CrossRefPubMed
51.
Zurück zum Zitat American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, et al. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care. 2008;31(Suppl 1):S61–78.CrossRef American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, et al. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care. 2008;31(Suppl 1):S61–78.CrossRef
52.
Zurück zum Zitat Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57–65.CrossRefPubMed Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57–65.CrossRefPubMed
53.
Zurück zum Zitat Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(1):77–82.CrossRefPubMed Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(1):77–82.CrossRefPubMed
54.
Zurück zum Zitat Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(18):1903–11.CrossRefPubMed Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(18):1903–11.CrossRefPubMed
55.
Zurück zum Zitat Nau KC, Lorenzetti RC, Cucuzzella M, Devine T, Kline J. Glycemic control in hospitalized patients not in intensive care: Beyond sliding-scale insulin. Am Fam Physician. 2010;81(9):1130–5.PubMed Nau KC, Lorenzetti RC, Cucuzzella M, Devine T, Kline J. Glycemic control in hospitalized patients not in intensive care: Beyond sliding-scale insulin. Am Fam Physician. 2010;81(9):1130–5.PubMed
56.
Zurück zum Zitat Guthrie DW, Guthrie RA, Hinnen D, Childs BP. It's time to abandon the sliding scale. J Fam Pract. 2011;60(5):266–70.PubMed Guthrie DW, Guthrie RA, Hinnen D, Childs BP. It's time to abandon the sliding scale. J Fam Pract. 2011;60(5):266–70.PubMed
57.
Zurück zum Zitat Page RL, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.CrossRefPubMedPubMedCentral Page RL, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Hinzmann R, Schlaeger C, Tran CT. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes? Int J Med Sci. 2012;9(8):665–81.CrossRefPubMedPubMedCentral Hinzmann R, Schlaeger C, Tran CT. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes? Int J Med Sci. 2012;9(8):665–81.CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94(2):564–9.CrossRefPubMed Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94(2):564–9.CrossRefPubMed
60.
Zurück zum Zitat • Bellido V, Suarez L, Rodriguez MG, Sanchez C, Dieguez M, Riestra M, et al. Comparison of basal-bolus and premixed insulin regimens in hospitalized patients with type 2 diabetes. Diabetes Care. 2015;38(12):2211–6. This study shows the importance of avoiding premixed insulin in the hospital setting CrossRefPubMedPubMedCentral • Bellido V, Suarez L, Rodriguez MG, Sanchez C, Dieguez M, Riestra M, et al. Comparison of basal-bolus and premixed insulin regimens in hospitalized patients with type 2 diabetes. Diabetes Care. 2015;38(12):2211–6. This study shows the importance of avoiding premixed insulin in the hospital setting CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: Basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract. 2008 Dec;14(9):1095–101.CrossRefPubMed Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: Basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract. 2008 Dec;14(9):1095–101.CrossRefPubMed
62.
Zurück zum Zitat King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Bolus dosing. J Diabetes Sci Technol. 2007;1(1):42–6.CrossRefPubMedPubMedCentral King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Bolus dosing. J Diabetes Sci Technol. 2007;1(1):42–6.CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Leonhardi BJ, Boyle ME, Beer KA, Seifert KM, Bailey M, Miller-Cage V, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: A review of one institution's experience. J Diabetes Sci Technol. 2008;2(6):948–62.CrossRefPubMedPubMedCentral Leonhardi BJ, Boyle ME, Beer KA, Seifert KM, Bailey M, Miller-Cage V, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: A review of one institution's experience. J Diabetes Sci Technol. 2008;2(6):948–62.CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Nassar AA, Partlow BJ, Boyle ME, Castro JC, Bourgeois PB, Cook CB. Outpatient-to-inpatient transition of insulin pump therapy: Successes and continuing challenges. J Diabetes Sci Technol. 2010;4(4):863–72.CrossRefPubMedPubMedCentral Nassar AA, Partlow BJ, Boyle ME, Castro JC, Bourgeois PB, Cook CB. Outpatient-to-inpatient transition of insulin pump therapy: Successes and continuing challenges. J Diabetes Sci Technol. 2010;4(4):863–72.CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Cook CB, Beer KA, Seifert KM, Boyle ME, Mackey PA, Castro JC. Transitioning insulin pump therapy from the outpatient to the inpatient setting: A review of 6 years' experience with 253 cases. J Diabetes Sci Technol. 2012;6(5):995–1002.CrossRefPubMedPubMedCentral Cook CB, Beer KA, Seifert KM, Boyle ME, Mackey PA, Castro JC. Transitioning insulin pump therapy from the outpatient to the inpatient setting: A review of 6 years' experience with 253 cases. J Diabetes Sci Technol. 2012;6(5):995–1002.CrossRefPubMedPubMedCentral
66.
Zurück zum Zitat Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and Management of Diabetes in Canada. Can J Diabetes. 2013;37(suppl 1):S1–S212. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and Management of Diabetes in Canada. Can J Diabetes. 2013;37(suppl 1):S1–S212.
67.
68.
Zurück zum Zitat Munt R, Hutton A. Type 1 diabetes mellitus (T1DM) self management in hospital; is it possible? A literature review. Contemp Nurse. 2012;40(2):179–93.CrossRefPubMed Munt R, Hutton A. Type 1 diabetes mellitus (T1DM) self management in hospital; is it possible? A literature review. Contemp Nurse. 2012;40(2):179–93.CrossRefPubMed
69.
Zurück zum Zitat Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40(12):3251–76.CrossRefPubMed Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40(12):3251–76.CrossRefPubMed
70.
Zurück zum Zitat Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82.CrossRefPubMed Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82.CrossRefPubMed
71.
Zurück zum Zitat Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001–9.CrossRefPubMedPubMedCentral Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001–9.CrossRefPubMedPubMedCentral
72.
Zurück zum Zitat Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007–21.CrossRefPubMed Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007–21.CrossRefPubMed
73.
Zurück zum Zitat van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.CrossRefPubMed van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.CrossRefPubMed
74.
Zurück zum Zitat Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–7.CrossRefPubMed Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–7.CrossRefPubMed
75.
Zurück zum Zitat Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: A review of 12 protocols. Diabetes Care. 2007;30(4):1005–11.CrossRefPubMed Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: A review of 12 protocols. Diabetes Care. 2007;30(4):1005–11.CrossRefPubMed
76.
Zurück zum Zitat American Diabetes Association (ADA). Standards of Medical Care in Diabetes. Diabetes Care 2015; 38(S1-S2). American Diabetes Association (ADA). Standards of Medical Care in Diabetes. Diabetes Care 2015; 38(S1-S2).
77.
Zurück zum Zitat Newton CA, Smiley D, Bode BW, Kitabchi AE, Davidson PC, Jacobs S, et al. A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. standard column-based algorithms. J Hosp Med. 2010;5(8):432–7.CrossRefPubMedPubMedCentral Newton CA, Smiley D, Bode BW, Kitabchi AE, Davidson PC, Jacobs S, et al. A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. standard column-based algorithms. J Hosp Med. 2010;5(8):432–7.CrossRefPubMedPubMedCentral
78.
Zurück zum Zitat Tanenberg RJ, Hardee S, Rothermel C, Drake AJ R. Use of a Computer-Guided Glucose Management System to Improve Glycemic Control and Address National Quality Measures: a 7-Year Retrospective Observational Study at a Tertiary Care Teaching Hospital. Endocr Pract 2016; 14. Tanenberg RJ, Hardee S, Rothermel C, Drake AJ R. Use of a Computer-Guided Glucose Management System to Improve Glycemic Control and Address National Quality Measures: a 7-Year Retrospective Observational Study at a Tertiary Care Teaching Hospital. Endocr Pract 2016; 14.
79.
Zurück zum Zitat Kuntschen F, Galletti PM, Hahn C. Blood glucose control by closed loop insulin delivery during coronary artery bypass surgery. Trans Am Soc Artif Intern Organs. 1981;27:241–5.PubMed Kuntschen F, Galletti PM, Hahn C. Blood glucose control by closed loop insulin delivery during coronary artery bypass surgery. Trans Am Soc Artif Intern Organs. 1981;27:241–5.PubMed
80.
Zurück zum Zitat Watson BG, Elliott MJ, Pay DA, Williamson M. Diabetes mellitus and open heart surgery. A simple, practical closed-loop insulin infusion system for blood glucose control. Anaesthesia. 1986;41(3):250–7.CrossRefPubMed Watson BG, Elliott MJ, Pay DA, Williamson M. Diabetes mellitus and open heart surgery. A simple, practical closed-loop insulin infusion system for blood glucose control. Anaesthesia. 1986;41(3):250–7.CrossRefPubMed
81.
Zurück zum Zitat Yatabe T, Nakamura R, Kitagawa H, Munekage M, Hanazaki K. A case of perioperative glucose control by using an artificial pancreas in a patient with glycogen storage disease. J Artif Organs. 2016;19(1):100–3.CrossRefPubMed Yatabe T, Nakamura R, Kitagawa H, Munekage M, Hanazaki K. A case of perioperative glucose control by using an artificial pancreas in a patient with glycogen storage disease. J Artif Organs. 2016;19(1):100–3.CrossRefPubMed
82.
Zurück zum Zitat •• Namikawa T, Munekage M, Kitagawa H, Yatabe T, Maeda H, Tsukamoto Y, et al. Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system. J Artif Organs 2016 20. This study shows successful utilization of a closed loop artificial pancreas in the perioperative period •• Namikawa T, Munekage M, Kitagawa H, Yatabe T, Maeda H, Tsukamoto Y, et al. Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system. J Artif Organs 2016 20. This study shows successful utilization of a closed loop artificial pancreas in the perioperative period
83.
Zurück zum Zitat Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Maeda H, Yatabe T, et al. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: A prospective randomized clinical trial. Arch Surg. 2009;144(10):933–7.CrossRefPubMed Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Maeda H, Yatabe T, et al. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: A prospective randomized clinical trial. Arch Surg. 2009;144(10):933–7.CrossRefPubMed
84.
Zurück zum Zitat Hanazaki K, Kitagawa H, Yatabe T, Munekage M, Dabanaka K, Takezaki Y, et al. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: The effects of no hypoglycemia. Am J Surg. 2014;207(6):935–41.CrossRefPubMed Hanazaki K, Kitagawa H, Yatabe T, Munekage M, Dabanaka K, Takezaki Y, et al. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: The effects of no hypoglycemia. Am J Surg. 2014;207(6):935–41.CrossRefPubMed
85.
Zurück zum Zitat Maeda H, Okabayashi T, Yatabe T, Yamashita K, Hanazaki K. Perioperative intensive insulin therapy using artificial endocrine pancreas in patients undergoing pancreatectomy. World J Gastroenterol. 2009;15(33):4111–5.CrossRefPubMedPubMedCentral Maeda H, Okabayashi T, Yatabe T, Yamashita K, Hanazaki K. Perioperative intensive insulin therapy using artificial endocrine pancreas in patients undergoing pancreatectomy. World J Gastroenterol. 2009;15(33):4111–5.CrossRefPubMedPubMedCentral
86.
Zurück zum Zitat Yatabe T, Nishigaki A, Kitagawa H, Namikawa T, Hanazaki K, Yokoyama M. Successful treatment of hyperkalaemia with insulin therapy using a closed-loop glycaemic control device. Anaesth Intensive Care. 2016;44(2):294–5.PubMed Yatabe T, Nishigaki A, Kitagawa H, Namikawa T, Hanazaki K, Yokoyama M. Successful treatment of hyperkalaemia with insulin therapy using a closed-loop glycaemic control device. Anaesth Intensive Care. 2016;44(2):294–5.PubMed
87.
Zurück zum Zitat Tsukamoto Y, Kinoshita Y, Kitagawa H, Munekage M, Munekage E, Takezaki Y, et al. Evaluation of a novel artificial pancreas: Closed loop glycemic control system with continuous blood glucose monitoring. Artif Organs. 2013;37(4):E67–73.CrossRefPubMed Tsukamoto Y, Kinoshita Y, Kitagawa H, Munekage M, Munekage E, Takezaki Y, et al. Evaluation of a novel artificial pancreas: Closed loop glycemic control system with continuous blood glucose monitoring. Artif Organs. 2013;37(4):E67–73.CrossRefPubMed
88.
Zurück zum Zitat McDonnell ME, Umpierrez GE. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin N Am. 2012;41(1):175–201.CrossRef McDonnell ME, Umpierrez GE. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin N Am. 2012;41(1):175–201.CrossRef
89.
Zurück zum Zitat Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, et al. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012;97(9):3132–7.CrossRefPubMed Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, et al. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012;97(9):3132–7.CrossRefPubMed
90.
Zurück zum Zitat Mucha GT, Merkel S, Thomas W, Bantle JP. Fasting and insulin glargine in individuals with type 1 diabetes. Diabetes Care. 2004;27(5):1209–10.CrossRefPubMed Mucha GT, Merkel S, Thomas W, Bantle JP. Fasting and insulin glargine in individuals with type 1 diabetes. Diabetes Care. 2004;27(5):1209–10.CrossRefPubMed
91.
Zurück zum Zitat Tridgell DM, Tridgell AH, Hirsch IB. Inpatient management of adults and children with type 1 diabetes. Endocrinol Metab Clin N Am. 2010;39(3):595–608.CrossRef Tridgell DM, Tridgell AH, Hirsch IB. Inpatient management of adults and children with type 1 diabetes. Endocrinol Metab Clin N Am. 2010;39(3):595–608.CrossRef
92.
Zurück zum Zitat Bevier WC, Zisser HC, Jovanovic L, Finan DA, Palerm CC, Seborg DE, et al. Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone. J Diabetes Sci Technol. 2008;2(4):578–83.CrossRefPubMedPubMedCentral Bevier WC, Zisser HC, Jovanovic L, Finan DA, Palerm CC, Seborg DE, et al. Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone. J Diabetes Sci Technol. 2008;2(4):578–83.CrossRefPubMedPubMedCentral
93.
94.
Zurück zum Zitat Braithwaite SS. Inpatient insulin therapy. Curr Opin Endocrinol Diabetes Obes. 2008;15(2):159–66.CrossRefPubMed Braithwaite SS. Inpatient insulin therapy. Curr Opin Endocrinol Diabetes Obes. 2008;15(2):159–66.CrossRefPubMed
95.
Zurück zum Zitat Via MA, Mechanick JI. Inpatient enteral and parenteral [corrected] nutrition for patients with diabetes. Curr Diab Rep. 2011;11(2):99–105.CrossRefPubMed Via MA, Mechanick JI. Inpatient enteral and parenteral [corrected] nutrition for patients with diabetes. Curr Diab Rep. 2011;11(2):99–105.CrossRefPubMed
96.
Zurück zum Zitat Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, et al. ESPEN guidelines on enteral nutrition: Intensive care. Clin Nutr. 2006;25(2):210–23.CrossRefPubMed Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, et al. ESPEN guidelines on enteral nutrition: Intensive care. Clin Nutr. 2006;25(2):210–23.CrossRefPubMed
97.
Zurück zum Zitat Leon-Sanz M, Garcia-Luna PP, Sanz-Paris A, Gomez-Candela C, Casimiro C, Chamorro J, et al. Glycemic and lipid control in hospitalized type 2 diabetic patients: Evaluation of 2 enteral nutrition formulas low carbohydrate-high monounsaturated fat vs high carbohydrate. JPEN J Parenter Enteral Nutr. 2005;29(1):21–29. Leon-Sanz M, Garcia-Luna PP, Sanz-Paris A, Gomez-Candela C, Casimiro C, Chamorro J, et al. Glycemic and lipid control in hospitalized type 2 diabetic patients: Evaluation of 2 enteral nutrition formulas low carbohydrate-high monounsaturated fat vs high carbohydrate. JPEN J Parenter Enteral Nutr. 2005;29(1):21–29.
98.
Zurück zum Zitat Craig LD, Nicholson S, SilVerstone FA, Kennedy RD. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: Results of a pilot trial. Nutrition. 1998;14(6):529–34.CrossRefPubMed Craig LD, Nicholson S, SilVerstone FA, Kennedy RD. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: Results of a pilot trial. Nutrition. 1998;14(6):529–34.CrossRefPubMed
99.
Zurück zum Zitat Pasquel FJ, Spiegelman R, McCauley M, Smiley D, Umpierrez D, Johnson R, et al. Hyperglycemia during total parenteral nutrition: An important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010;33(4):739–41.CrossRefPubMed Pasquel FJ, Spiegelman R, McCauley M, Smiley D, Umpierrez D, Johnson R, et al. Hyperglycemia during total parenteral nutrition: An important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010;33(4):739–41.CrossRefPubMed
Metadaten
Titel
Management of Type 1 Diabetes in the Hospital Setting
verfasst von
Carlos E. Mendez
Guillermo E. Umpierrez
Publikationsdatum
01.10.2017
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 10/2017
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0919-7

Weitere Artikel der Ausgabe 10/2017

Current Diabetes Reports 10/2017 Zur Ausgabe

Therapies and New Technologies in the Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor)

Multivariable Adaptive Artificial Pancreas System in Type 1 Diabetes

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Cardiovascular and Mortality Risks in Migrant South Asians with Type 2 Diabetes: Are We Winning the Battle?

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Diameter Changes of Retinal Vessels in Diabetic Retinopathy

Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors)

The Effects of Chronic Aerobic Exercise on Cardiovascular Risk Factors in Persons with Diabetes Mellitus

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Intraocular Inflammation in Diabetic Populations

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.